Skip to content

Impact of body composition on early recurrence in participants with pancreatic cancer

Impact of body composition on early recurrence in participants with pancreatic cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104390
Enrollment
Unknown
Registered
2025-06-16
Start date
2025-05-24
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

Pancreatic cancer observational group:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
36 Years to 81 Years

Inclusion criteria

Inclusion criteria: 1. Participants undergoing radical resection; 2. PDAC confirmed by postoperative pathology; 3. Abdominal CT plain scan completed within 30 days prior to surgery with good image quality; 4. Resectable pancreatic cancer as defined in the NCCN criteria; 5. Complete clinical, preoperative biochemical, pathological and at least 12 months postoperative follow-up data or tumor recurrence has been clarified within 12 months.

Exclusion criteria

Exclusion criteria: 1. Those who received any form of preoperative neoadjuvant therapy (e.g., preoperative chemotherapy, radiotherapy, or combination of radiotherapy and chemotherapy); 2. Those with preoperative distant metastases or unresectable locally progressive tumors; 3. Those who died within 30 days of surgery; 4. Those who had poor quality preoperative CT images (e.g., severe respiratory motion artifacts) or missing image data; 5. Those with incomplete clinical or follow-up data.

Design outcomes

Primary

MeasureTime frame
skeletal muscle index;skeletal muscle density;visceral adipose tissue area;visceral adipose tissue volume;subcutaneous adipose tissue area;subcutaneous adipose tissue volume;early recurrence;

Countries

China

Contacts

Public ContactZixing Huang

West China Hospital, Sichuan University

zixinghuang@hotmail.com+86 138 8220 6874

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026